As a matter of fact, CAIX, which catalyses the reversible hydration of carbon dioxide (as CAXII), contains in its gene promoter an HRE, so it may be considered a biomarker of tumour hypoxia [24]. The gene discussed is CA9; the disease is neoplasm.